Funding for this research was provided by:
National Cancer Institute (R01CA193396)
Received: 19 September 2019
Accepted: 24 May 2020
First Online: 23 June 2020
Ethics approval and consent to participate
: Essentia Health’s Institutional Review Board (IRB) approved this study and waived documentation of informed consent (EIRH-16-1550). As the care recommendations in the intervention were limited to evidence-based care from current national clinical guidelines and represented minimal risk, the IRB granted waivers of consent for PCPs and patients to use the CDS in clinical care. Research staff are not in contact with patients. PHI collected for use by the study is not part of the study analysis.
: Not applicable.
: The authors declare that they have no competing interests.